Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells

Gonadotropin releasing hormone analogues (GnRHa) are often used to regress endometriosis implants and prevent premature luteinizing hormone surges in women undergoing controlled ovarian stimulation. In addition to GnRH central action, the expression of GnRH and receptors in the endometrium implies a...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiaoping, Xu, Jingxia, Chegini, Nasser
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317376/
https://www.ncbi.nlm.nih.gov/pubmed/14678567
http://dx.doi.org/10.1186/1477-7827-1-125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317376/
https://www.ncbi.nlm.nih.gov/pubmed/14678567
http://dx.doi.org/10.1186/1477-7827-1-125

Ejemplares similares